Going to the AGM and will give you guys a run down.ENB have said in their QTRLY they are speaking with potential customers so may have some nice surprises in the months to come.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress